Alzheimer’s genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent manner
Fanny Eysert(Centre National de la Recherche Scientifique), Julien Chapuis(Inserm), Florie Demiautte(Inserm), Jean‐Charles Lambert(Inserm), Mari Takalo(University of Eastern Finland), Audrey Coulon(Inserm), Emmanuelle Boscher(Centre hospitalier de l'Université Laval), Sébastien Hébert(Centre hospitalier de l'Université Laval), Mélissa Farinelli(École Polytechnique Fédérale de Lausanne), Charlotte Bauer(Centre National de la Recherche Scientifique), Julie Dumont(Inserm), Philippe Amouyel(Institut Pasteur de Lille), Mikael Marttinen(University of Eastern Finland), Amandine Flaig(Inserm), Sandrine Hughes(Université Claude Bernard Lyon 1), Devrim Kilinc(Inserm), Tiago Mendes(Inserm), Mikko Hiltunen(University of Eastern Finland), Frédéric Checler(Centre National de la Recherche Scientifique), Anaїs-Camille Vreulx(Inserm), Shruti Desai(Inserm), Nicolas Malmanche(Universidade do Porto), Benjamin Grenier‐Boley(University of Bonn), Xavier Hanoulle(Centre National de la Recherche Scientifique), Charlotte Delay(Inserm), Ian Pike(Proteome Sciences (United Kingdom))
Cited by 59
Related Papers
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
|The Lancet|2016|4.4k
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.6k